NFG
FLGT icon

Norris Financial Group’s Fulgent Genetics FLGT Stock Holding History

Norris Financial Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,398
Closed -$459K – 73
2022
Q4 		$459K Sell
15,398
-3,168
-17% -$113K 0.39% 44
2022
Q3 		$708K Sell
18,566
-675
-4% -$33.8K 0.65% 34
2022
Q2 		$1.05M Sell
19,241
-4,048
-17% -$222K 0.84% 30
2022
Q1 		$1.45M Buy
23,289
+10,399
+81% +$685K 0.88% 28
2021
Q4 		$1.3M Buy
12,890
+4,405
+52% +$387K 0.78% 30
2021
Q3 		$763K Buy
8,485
+325
+4% +$29.5K 0.5% 45
2021
Q2 		$753K Buy
+8,160
New +$652K 0.51% 49

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Norris Financial Group's FLGT Position: Q1 2023 in Review

Norris Financial Group sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 15,398 shares — an estimated $459K sold.

Norris Financial Group first reported a position in FLGT in Q2 2021 and held it in 7 quarters. The position peaked at $1.45M in Q1 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Norris Financial Group reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Norris Financial Group sold 15,398 Fulgent Genetics shares in Q1 2023, an estimated $459K.
  • Norris Financial Group first reported a position in Fulgent Genetics in Q2 2021 and held it in 7 quarters.
  • Norris Financial Group's Fulgent Genetics position peaked at $1.45M in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Norris Financial Group's 13F filing for Q1 2023, filed 20 May 2026.